share_log

JMP Securities Maintains Market Outperform on BioAtla, Lowers Price Target to $5

Benzinga ·  May 24 00:09

JMP Securities analyst Reni Benjamin maintains BioAtla (NASDAQ:BCAB) with a Market Outperform and lowers the price target from $12 to $5.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment